Clinical Trials for Candel Therapeutics

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Candel Therapeutics

Clinical Trials (5)

NCT04495153
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
PHASE2Active, not recruiting
90 participants
Started: Oct 13, 2020 · Completed: Dec 31, 2026
1 condition2 sponsors14 locations
NCT03152318
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
PHASE1Recruiting
62 participants
Started: Jul 18, 2017 · Completed: Jan 31, 2027
14 conditions3 sponsors5 locations
NCT02768363
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
PHASE2Active, not recruiting
187 participants
Started: May 31, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor23 locations
NCT02446093
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
PHASE2Active, not recruiting
54 participants
Started: Oct 31, 2015 · Completed: Jul 31, 2026
1 condition2 sponsors3 locations
NCT01436968
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
PHASE3Active, not recruiting
711 participants
Started: Sep 30, 2011 · Completed: Dec 31, 2030
1 condition1 sponsor73 locations